- Home
- YUMC vs BAX Comparison
YUMC vs BAX Comparison
Compare YUMC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YUMC
- BAX
- Stock Information
- Founded
- YUMC 1987
- BAX 1931
- Country
- YUMC China
- BAX United States
- Employees
- YUMC N/A
- BAX N/A
- Industry
- YUMC Restaurants
- BAX Medical/Dental Instruments
- Sector
- YUMC Consumer Discretionary
- BAX Health Care
- Exchange
- YUMC Nasdaq
- BAX Nasdaq
- Market Cap
- YUMC 16.4B
- BAX 15.6B
- IPO Year
- YUMC N/A
- BAX N/A
- Fundamental
- Price
- YUMC $43.63
- BAX $30.49
- Analyst Decision
- YUMC Buy
- BAX Buy
- Analyst Count
- YUMC 2
- BAX 8
- Target Price
- YUMC $48.70
- BAX $37.25
- AVG Volume (30 Days)
- YUMC 2.6M
- BAX 3.5M
- Earning Date
- YUMC 04-30-2025
- BAX 05-01-2025
- Dividend Yield
- YUMC 2.20%
- BAX 2.23%
- EPS Growth
- YUMC 19.63
- BAX N/A
- EPS
- YUMC 2.38
- BAX N/A
- Revenue
- YUMC $11,326,000,000.00
- BAX $10,771,000,000.00
- Revenue This Year
- YUMC $6.02
- BAX $8.06
- Revenue Next Year
- YUMC $6.09
- BAX $4.19
- P/E Ratio
- YUMC $18.33
- BAX N/A
- Revenue Growth
- YUMC 2.79
- BAX 15.36
- 52 Week Low
- YUMC $28.50
- BAX $26.25
- 52 Week High
- YUMC $53.99
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- YUMC 45.81
- BAX 47.96
- Support Level
- YUMC $41.92
- BAX $29.72
- Resistance Level
- YUMC $45.01
- BAX $31.04
- Average True Range (ATR)
- YUMC 1.03
- BAX 0.72
- MACD
- YUMC 0.09
- BAX -0.03
- Stochastic Oscillator
- YUMC 33.63
- BAX 26.01
About YUMC Yum China Holdings Inc.
With more than 16,000 units and almost USD 12 billion in systemwide sales in 2024, Yum China is the largest restaurant operator in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (11,648 units) and Pizza Hut (3,724), but the company's portfolio also includes other brands such as Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza (collectively representing more than 1,000 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.